Sunfish Partners

Zaitra is a space and science software company focused on enhancing data transmission efficiency and intelligence for space missions. The company specializes in developing onboard data processing systems and flight software for space-grade instruments, aiming to revolutionize data processing both on Earth and in space, including lunar operations. By integrating artificial intelligence into its solutions, Zaitra enables smart in-orbit data processing, facilitating cost reduction in data transmission and optimizing the management of information gathered during missions.

1.security is an operator of a cybersecurity platform designed to manage the Microsoft environment. The company's platform enables customers to manage third-party app permissions, gain real-time insights using Microsoft 365 reporting, and detect threats, allowing them to safely manage their data.

Orbital Matter is a construction company based in Warsaw, Poland, founded in 2022. The company specializes in using 3D printing technology to manufacture large elements of space infrastructure directly in orbit, on the Moon, and potentially on Mars. Orbital Matter's services include constructing walls for space stations, moon habitats, and solar power satellite reflectors, enabling clients to build complex structures of various sizes and shapes directly in space.

Solvemed Limited stands at the forefront of innovation in neurological care, leveraging advanced AI technology to pioneer precision diagnostics and personalized treatment recommendations. Our cutting-edge solutions empower healthcare professionals with unprecedented insights, enabling early detection and monitoring of neurological disorders such as Parkinson's disease. With a steadfast commitment to improving patient outcomes, we seamlessly integrate our AI-driven platform to revolutionize the landscape of neurology diagnostics and drug discovery. Backed by a dedicated team of experts and powered by state-of-the-art technology, Solvemed Limited remains steadfast in its mission to redefine the standards of neurological care worldwide.

Smarter Diagnostics develops AI-based software for analyzing magnetic resonance images in orthopedics and sports medicine. The platform supports radiology by identifying soft-tissue musculoskeletal disorders, enabling early detection of injury-causing pathologies and preventive measures. It also offers structural assessments, metabolism analysis, and motion accuracy evaluation to help athletes optimize performance, reduce injury risk, and lower financial losses. The solutions are applicable in clinical settings and for screening and health checks of active individuals, from amateurs to professionals.

CliniNote develops an adaptive AI platform designed to enhance health systems through clinical AI integration. The company focuses on seamlessly integrating its technology with hospital Electronic Medical Records (EMR) systems to revolutionize the use of Real-World Data in healthcare. CliniNote collaborates with medical professionals to generate high-quality data with minimal disruption to existing procedures, providing structured clinical information to support their work. Currently, the platform is primarily used for automating Clinical Trials and Real-World Data studies. The company's future vision includes accelerating AI adoption within clinical workflows and transforming how clinical data is generated and utilized.

Liftero is a Polish company that specializes in developing high-thrust chemical propulsion systems for the space market. Founded in May 2023, Liftero's flagship product, BOOSTER, allows satellite operators to carry out maneuvers ten times faster than traditional methods, significantly reducing operational losses and enhancing return on investment. The BOOSTER system utilizes environmentally friendly propellants that are cost-effective and easy to handle, making them suitable for integration with various launchers and rideshare missions. Leveraging automation and advanced manufacturing techniques, Liftero is able to deliver ready-to-integrate propulsion systems three times faster than industry standards. The company is set to see its first BOOSTER unit fly aboard the SpaceX Transporter-13 mission in the first quarter of 2025, marking a significant milestone ahead of its product launch and initial customer deliveries.

Solvemed Limited stands at the forefront of innovation in neurological care, leveraging advanced AI technology to pioneer precision diagnostics and personalized treatment recommendations. Our cutting-edge solutions empower healthcare professionals with unprecedented insights, enabling early detection and monitoring of neurological disorders such as Parkinson's disease. With a steadfast commitment to improving patient outcomes, we seamlessly integrate our AI-driven platform to revolutionize the landscape of neurology diagnostics and drug discovery. Backed by a dedicated team of experts and powered by state-of-the-art technology, Solvemed Limited remains steadfast in its mission to redefine the standards of neurological care worldwide.

Solvemed Group is a neuroscience artificial intelligence company focused on transforming patient care and drug discovery in the realm of neurodegenerative diseases, particularly Parkinson's disease. The company utilizes proprietary machine learning technology to create innovative diagnostic and predictive digital biomarkers, which facilitate accurate, early, and cost-effective diagnosis and monitoring tools for patients and healthcare professionals. By addressing the unmet needs of neurological patients, Solvemed aims to provide reliable diagnostics that enhance treatment outcomes and improve overall quality of care. Moreover, the company's advancements in biomarker development support the creation of disease-modifying drugs, thereby optimizing clinical trial efficiency in collaboration with biopharmaceutical partners. The team at Solvemed comprises leading scientists and technology experts who collaborate with renowned research institutions globally, ensuring that their work is anchored in world-class science and contributes to improving healthcare systems while alleviating the financial burdens associated with inadequate diagnostics.

Codejet is a developer of a web design platform that streamlines front-end development for web and mobile applications. The platform enables developers to quickly transform ready-made websites into functional applications through a one-click conversion to code. It features a visual editor that allows for easy modifications, significantly reducing the time required to launch projects. By utilizing various frameworks and libraries, Codejet promotes the use of reusable code, which helps developers avoid repetitive coding tasks. This approach empowers clients to efficiently turn their ideas into reliable and user-friendly applications.

Smarter Diagnostics develops AI-based software for analyzing magnetic resonance images in orthopedics and sports medicine. The platform supports radiology by identifying soft-tissue musculoskeletal disorders, enabling early detection of injury-causing pathologies and preventive measures. It also offers structural assessments, metabolism analysis, and motion accuracy evaluation to help athletes optimize performance, reduce injury risk, and lower financial losses. The solutions are applicable in clinical settings and for screening and health checks of active individuals, from amateurs to professionals.

CodeAlly is a talent marketplace focused on connecting employers with developers through a comprehensive verification process. The company operates a platform that facilitates both passive and active hiring, enabling businesses to post jobs while assessing candidates based on their skills rather than solely on work history. Developers, including those without prior experience, can enhance their employability by undergoing a certification process, which bolsters employer confidence in their abilities. Additionally, CodeAlly partners with programming schools to provide tailored developer profile recommendations to companies seeking talent, while also offering job recommendations to developers in its network. The platform has seen significant growth, with over 1,000 developers joining its talent pool weekly.

Deepflare is a tech bio AI company that specializes in accelerating the development of cancer vaccines and immunotherapies for pharmaceutical firms. The company offers a machine learning suite that predicts T-cell responses and identifies critical epitopes, which enhances the immunogenicity of antigens. By leveraging its in silico antigen discovery platform, Deepflare aims to streamline pre-clinical research processes, thereby reducing costs and improving the efficacy of treatments. This innovative approach enables laboratories to validate their potential tests against a comprehensive analysis of viral genome data.

Pergamin is a Polish startup founded in 2017 that specializes in developing a proprietary online platform for contract management in a SaaS model. The company focuses on streamlining the contracting process for business and HR contracts by enabling users to automatically create, negotiate, sign, and store documents digitally. Pergamin's platform transforms contracts into modular templates and supports data exchange with various tools, such as CRM and HR management systems. By incorporating features like electronic signatures and automatic verification of contractors' data against external databases, Pergamin significantly reduces the time-to-signature and minimizes human errors, thereby eliminating the need for traditional paper-based processes.

Alphamoon is a technology company that specializes in document automation and data extraction. It has developed an advanced platform that leverages artificial intelligence and natural language processing to streamline the document processing workflow. By automating the collection and processing of data from various document formats, Alphamoon significantly reduces both the time and costs associated with these tasks. The company's solutions are particularly beneficial for enhancing the debt recovery process, allowing clients to efficiently process documents and extract valuable information with ease.

Scramjet is a developer of open-source cloud software that specializes in transforming data-in-motion efficiently. The company offers a computing platform that integrates stream processing with serverless cloud computing and supports deployment across various environments, including edge, on-premises, and cloud. This versatile approach enables organizations in diverse sectors such as automotive, IoT, machine learning, and business intelligence to process and analyze data of any size from multiple sources. Scramjet aims to provide a powerful yet simple computing engine that enhances data transformation capabilities, making it an essential tool for modern data-driven applications.

Aether Biomedical is a medical robotics startup specializing in artificial intelligence-driven biomedical signal processing to develop rehabilitation robotics devices. The company has created Zeus, a multi-action bionic limb designed to offer a cost-effective and highly effective solution for upper limb amputees. This advanced prosthetic arm utilizes biosignal processing to provide a functional prosthesis that enables users to perform daily tasks with ease. Its unique design allows for individual control of the fingers, facilitating a proper grip that conforms to various objects' shapes. By integrating innovative medical technology, Aether Biomedical aims to enhance the quality of life for amputees.

re_data is an early-stage startup that has developed an open-source framework for ensuring data reliability within the modern data stack. The company's platform enables users to monitor and track anomalies in data pipelines, facilitating swift identification and resolution of underlying issues. By providing tools to build metrics for data tests and effectively manage data projects, re_data aims to enhance the trustworthiness of data, thereby reducing the risk of erroneous decisions stemming from "bad data." This initiative not only helps protect the reputation of businesses by preventing flawed data from reaching clients but also alleviates the workload of data and analytics engineers, allowing them to focus on more strategic tasks.

Molecule.one is a biotechnology company that specializes in artificial intelligence-driven software for chemical synthesis. Its m1 platform enhances the preclinical pipeline by maximizing efficiency in chemistry-related processes. The company’s software predicts the likelihood of synthesizing novel small molecules and automates significant portions of the manual work involved in synthesis design. By leveraging vast datasets that exceed human processing capabilities, Molecule.one enables clients to concentrate on drug candidates that are not only cost-effective to synthesize but also have a higher probability of success in the development process. This integration of AI into chemical synthesis represents a significant advancement in the field, streamlining workflows for bench chemists, data scientists, and computational chemists alike.

Solvemed Group is a neuroscience artificial intelligence company focused on transforming patient care and drug discovery in the realm of neurodegenerative diseases, particularly Parkinson's disease. The company utilizes proprietary machine learning technology to create innovative diagnostic and predictive digital biomarkers, which facilitate accurate, early, and cost-effective diagnosis and monitoring tools for patients and healthcare professionals. By addressing the unmet needs of neurological patients, Solvemed aims to provide reliable diagnostics that enhance treatment outcomes and improve overall quality of care. Moreover, the company's advancements in biomarker development support the creation of disease-modifying drugs, thereby optimizing clinical trial efficiency in collaboration with biopharmaceutical partners. The team at Solvemed comprises leading scientists and technology experts who collaborate with renowned research institutions globally, ensuring that their work is anchored in world-class science and contributes to improving healthcare systems while alleviating the financial burdens associated with inadequate diagnostics.

Aether Biomedical is a medical robotics startup specializing in artificial intelligence-driven biomedical signal processing to develop rehabilitation robotics devices. The company has created Zeus, a multi-action bionic limb designed to offer a cost-effective and highly effective solution for upper limb amputees. This advanced prosthetic arm utilizes biosignal processing to provide a functional prosthesis that enables users to perform daily tasks with ease. Its unique design allows for individual control of the fingers, facilitating a proper grip that conforms to various objects' shapes. By integrating innovative medical technology, Aether Biomedical aims to enhance the quality of life for amputees.

PerfOps is a Krakow-based company founded in 2017 that specializes in network analytics, offering a comprehensive platform designed to enhance the monitoring of global and distributed network applications. Its suite of products includes the PerfOps CLI, a command line tool for executing network tests and benchmarks, and PerfOps Network Utilities, which serves as a control panel for various network operations. The company also provides FlexBalancer, a cloud-based load-balancing service that optimizes internet traffic routing based on performance metrics. Additionally, PerfOps Analytics delivers insights into CDN, DNS, and cloud performance by analyzing billions of benchmarks. With a network of 300 global servers, PerfOps enables users to conduct on-demand network tests and troubleshoot services worldwide, facilitating competitive intelligence and issue diagnosis within network infrastructures.

Molecule.one is a biotechnology company that specializes in artificial intelligence-driven software for chemical synthesis. Its m1 platform enhances the preclinical pipeline by maximizing efficiency in chemistry-related processes. The company’s software predicts the likelihood of synthesizing novel small molecules and automates significant portions of the manual work involved in synthesis design. By leveraging vast datasets that exceed human processing capabilities, Molecule.one enables clients to concentrate on drug candidates that are not only cost-effective to synthesize but also have a higher probability of success in the development process. This integration of AI into chemical synthesis represents a significant advancement in the field, streamlining workflows for bench chemists, data scientists, and computational chemists alike.

PerfOps is a Krakow-based company founded in 2017 that specializes in network analytics, offering a comprehensive platform designed to enhance the monitoring of global and distributed network applications. Its suite of products includes the PerfOps CLI, a command line tool for executing network tests and benchmarks, and PerfOps Network Utilities, which serves as a control panel for various network operations. The company also provides FlexBalancer, a cloud-based load-balancing service that optimizes internet traffic routing based on performance metrics. Additionally, PerfOps Analytics delivers insights into CDN, DNS, and cloud performance by analyzing billions of benchmarks. With a network of 300 global servers, PerfOps enables users to conduct on-demand network tests and troubleshoot services worldwide, facilitating competitive intelligence and issue diagnosis within network infrastructures.

World’s first fully Autonomous Drone, powered by AI, requires no human pilot, no setup, no programming, handling everything from Takeoff & Landing to Aerial Reconnaissance & Navigation. Launch-Tube can be in a backpack, or installed on a fence. It’s very simple to install, and it’s low cost. The drone searches & navigates to humans. AI Detects humans faster & more accurate than humans can.